Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.

AptaIT GmbH is a bioinformatics company, which is dedicated to develop advanced software solutions for next-generation sequencing driven biomedical research. The company has developed a high-performance bioinformatics platform and a user-friendly desktop software for the discovery of novel biologics by in vitro selection strategies like phage, yeast, or mRNA display and SELEX. A second application segment is the analysis of the natural immune response mediated by b-cell and t-cell receptors (immunoprofiling). AptaIT offers tailored solutions for any customer. We provide custom NGS dataset analysis of libraries, in vitro selection experiments, or BCR/TCR repertoires as well as access to our innovative and user-friendly software tools.

Arrayjet are leading providers of innovative microarray solutions to researchers, drug development groups and diagnostic companies world-wide.

Founded in 2001, Arrayjet have vast microarray expertise with a laboratory team having in excess of 75 years combined experience. With an installation base across 25 countries world-wide, Arrayjet's technology is well established and proven.

Offering a flexible, customer focussed approach with the provision of Arrayjet Advance™ microarray services, our in-house printing service, in addition to four scalable microarray instruments ranging from 100 slides to 1000 slide fully automated mass manufacturing capacity. Arrayjet also offer consumables, accessories and service support to maximise instrument performance.

Arrayjet's platform technology uses unique, non-contact, inkjet printing offering unrivalled speed, reproducibility and precision. It delivers high quality microarrays faster than any other technology with the ability to print any sample type onto a wide variety of substrates. With a proven and well established printing technology and vast microarray expertise Arrayjet are your ideal partner whatever your microarray needs.

Further information available at www.arrayjet.com

ATUM (formerly DNA2.0) offers an integrated pipeline of solutions including gene design, optimization and synthesis, technology platforms for protein and strain engineering, and mammalian protein production and cell line development. ATUM explores novel applications of modern machine learning in combination with industrial scale gene synthesis for mega dimensional optimization of biological systems to industrialize biotechnology. The tools and technologies developed by ATUM are directly applicable to the pharmaceutical industry (e.g. protein pharmaceuticals, vaccines, gene therapy), agrochemical industry, diagnostics, food industry, and R&D throughout the life sciences. ATUM’s tools and solutions are fuelling the transformation of biology from a discovery science to an engineering discipline. The company is privately held and is headquartered in Newark, Calif. Visit www.atum.bio for more info.

Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership.

Bachem. Pioneering Partner for Peptides

Bio-Rad Laboratories is an expert manufacturer and supplier of antibodies for biotherapeutic development and characterization, immunodiagnostics and discovery research.

When you need customized reagents for PK and ADA assay development, no other company can rival our unique custom recombinant monoclonal antibody service that generates highly specific, high affinity antibodies in only 8 weeks. We use HuCAL® antibody library technology with a proprietary form of phage display to select antibodies to the most challenging antigens, such as antibody-target complexes, with simultaneous subtraction of unwanted specificities. Such antibodies are difficult to develop using traditional animal immunization methods.

For biosimilar developers and CROs providing large molecule bioanalytical services, our ready-made anti-biotherapeutic antibodies are ideally suited for highly specific and sensitive PK and immunogenicity assays. Our industry leading range includes antibodies against rituximab, infliximab, adalimumab, trastuzumab and bevacizumab.

Whether you need a ready-made product or a custom antibody generation project, we cater for all requirements and have satisfied clients for over 30 years. We aim to help you reach your goals by providing the antibodies you need and a professional, long-term partnership for success.

For further information visit bio-rad-antibodies.com/hucal.

Bio-Techne is the new trade name that brings together our trusted global brands. These brands and product lines are some of the most referenced in the life science industry and include R&D Systems, Novus Biologicals, Tocris Bioscience, and ProteinSimple. We have brought these brands together as Bio-Techne to be a stronger scientific partner to help you attain your research goals.

We offer the widest selection of high-quality reagents and instruments for the life science and diagnostic markets. Our new name represents our mission – to provide the life science community with innovative high-quality scientific tools to better understand biological processes and drive discovery.

Our vast product range includes:

Bioactive proteins – R&D Systems proteins are the industry’s premiere bioactive proteins, performance guaranteed and the most cited in the literature. A selection of the same high purity proteins are also available as GMP-grade, animal free or new ProDot lyophilised balls for easy preparation of cell culture medium.

Application-qualified Antibodies – a diverse and extensive analyte selection from Novus and R&D Systems, which covers 18,570 human gene products, as well as murine and multiple other species

Quantikine ELISA kits – legendary reproducibility and unrivalled reputation have made our ELISAs the gold standard

Luminex assays – the largest multiplex selection available, simultaneously analysing up to 100 analytes

Proteome Profiler Arrays – an easy to use, cost effective screening tool, with over 25 arrays to choose from

Small molecule activators and inhibitors – a unique collection of over 3,500 compounds, everything from the latest exclusively licensed research tools to establish biochemical standards.

ChemAxon provides chemical software solutions and applications for the biotechnology and pharmaceutical industries, which are successfully used in publishing, flavors and fragrances research, petroleum and fine chemicals development areas.

We bridge the gap between biology and chemistry with our web-enabled applications, the Biomolecule Toolkit and the BioEddie.

CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences. With a proven track record in scientific innovation, CCG continues to provide state-of-the-art applications in drug discovery to pharmaceutical, biotechnology and academic researchers. CCG’s software platform is the Molecular Operating Environment (MOE) which is used by computational chemists, medicinal chemists and biologists in the major pharmaceutical and biotechnology companies throughout the world. CCG has a very strong reputation for collaborative scientific support, maintaining support offices in both Europe and North America. Founded in 1994, CCG is headquartered in Montreal, Canada. For more information visit: www.chemcomp.com

C S Bio is a rapidly growing biotechnology company located on the northern edge of California’s Silicon Valley in Menlo Park, CA. C S Bio has grown to meet the increased demand for large quantities of cGMP produced peptides and Peptide APIs (Active Pharmaceutical Ingredients) which are produced at the Menlo Park production facility. As the world of biotechnology continues to utilize peptides more and more in the fields of therapeutics, vaccines, new drug discovery as well as bioengineering and nanotechnology, C S Bio is well positioned provide high quality clinical grade compounds to this rapidly growing industry. Our goal is to be able provide a seamless supply of peptide drugs and APIs to support the rapid growth of these programs. C S Bio has designed and built a state of the art large scale cGMP peptide manufacturing facility that can produce multi kilogram quantities for existing clients as well as new potential customers. C S Bio also features a complete line of automated peptide synthesizers with systems designed for R&D to large scale manufacturing systems of 500L and greater. These systems are validated for cGMP peptide drug production and can be found in peptide production laboratories and pharmaceutical companies worldwide.

Over the past several years C S Bio has cultivated relationships with several pharmaceutical companies that are poised take their peptide drugs to market in the near future. The company has taken several peptides from small scale R&D quantities to the point where we are now producing cGMP grade peptide in kilogram quantities. As the prospects of our client’s drug candidates grow, so does their need for larger batches of peptide for late stage clinical trials and eventually FDA approved peptide products on the market. C S Bio’s goal is to be able to meet and exceed those requirements and provide a seamless supply of peptide drugs to support the rapid growth of these programs. C S Bio has built a state of the art large scale cGMP peptide manufacturing facility that is capable of producing  multi kilogram quantities for these existing clients as well as new potential customers. No matter your peptide requirements, C S Bio will provide high quality service, compounds and equipment to ensure your peptide program's best chance for success.

DNASTAR has been developing innovative software to meet the needs of molecular biologists and structural biologists since 1984.  For the bulk of our history, we have supported life scientists performing traditional and next-generation DNA, RNA and protein sequence assembly, analysis and visualization.  We recently expanded our offering to include excellent products and pipelines supporting structural biology applications, including;

• Protein structure prediction
• Protein-protein docking
• Antibody, antigen and epitope binding predictions

At DNASTAR, we pride ourselves on our innovation.  We were at the forefront of molecular biology software when we started our company, we have been a leader in Next Generation Sequence (NGS) assembly and analysis software for the past decade, and we are now taking a leadership role in protein structure prediction, molecular docking software and related areas. The Lasergene Structural Biology Suite is based on best-in-class algorithms for protein structure prediction (I-TASSER) and docking (SwarmDock), as evidenced by objective competitions over many years.  We have incorporated these algorithms into easy to use workflows and powerful pipelines to help all biologists advance their protein research in silico. To complement the Lasergene Structural Biology Suite, DNSATAR also offers the Lasergene Genomics Suite, which provides everything needed for Next Generation Sequence assembly, alignment, and analysis in a single integrated package. We support all major NGS technologies and combined analysis with Sanger sequencing, making it easy to work with your data for any type of sequencing project.  DNASTAR’s proprietary NGS variant caller is the most accurate on the market, as validated using objective data and testing protocols. DNASTAR’s software is available on desktop computers, your in-house servers and on the Amazon cloud.  We want to ensure our software is available wherever and whenever you need it to accomplish your most important objectives. For each of the past 30 years, DNASTAR’s software has been cited in more peer reviewed publications than any other sequence analysis software package.  Scientists in more than 90 countries use DNASTAR software in their daily work and a broad range of organizations have adopted our software as their enterprise-wide DNA, RNA and protein sequence assembly and analysis solution. Free trial versions are available for all of our capabilities, as are a wealth of video tutorials and other support tools. Feel free to contact us at [email protected] to further discuss how to most effectively meet your research needs.

Evotec is a drug discovery solutions company providing drug discovery expertise and capabilities to pharmaceutical and biotechnology companies and to academic institutions. Solutions are provided in form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of innovative drug candidates and consulting arrangements. The Company operates worldwide and has leading scientific experts, state-of-the-art technologies as well as key therapeutic expertise in multiple areas including neuroscience, pain, metabolic diseases, oncology, inflammation and infectious diseases.

Expedeon develops and manufactures reagents and instruments for genomics and proteomics research, as well as providing services and free bioinformatics tools.

Expedeon supplies routine consumables with unique features such as InstantBlueTM Coomassie stain and RunBlueTM precast Bis-Tris protein gels, which are present in many laboratories and established in the scientific literature.

Additionally, we bring cutting-edge technologies and devices such as TruePrimeTM for unbiased amplification of single-cell whole genomes or circulating-tumour DNA, and the GelFree® for fractionation of whole proteomes. Expedeon aims to both support and advance genomics and proteomics research through developing and providing innovative products and technologies.

Expedeon operates worldwide and has laboratories and facilities in the UK (Cambridge), the USA (San Diego), Europe (Heidelberg & Madrid) and Asia (Singapore). The company provides products to all types of organisations and laboratories including academic and clinical research, and to biotech and pharmaceutical companies.

We are a company that is committed to excellent customer service and expert technical support.

Market Leader in Label-Free Analysis Technologies

Pall ForteBio is a division of Pall Life Sciences that provides a complete solution of system, software, accessories, and reagents for label-free analysis.

Label-free interaction analysis is of increasing importance in the academic, pharmaceutical, and biotechnology markets. Detecting the formation and dissociation of molecular complexes enables the comprehensive characterization of biomolecular interactions and stability.

In contrast to traditional label-free systems, Octet and BLItz systems operate without the use of microfluidics, allowing for up to 6x higher throughput, reducing operating costs, and increasing system flexibility to accommodate a variety of sample types.

The information-rich data enable key insights into biological processes and molecular binding mechanisms. These technologies meet the needs of fields as diverse as biological research, biotherapeutic and small molecule drug development research, vaccine development and QC.

Customers using ForteBio’s label-free technology can draw confident conclusions about biomolecular interactions to facilitate development and process decisions.

Found in 1998, GL BIOCHEM is specializing in peptide reagents, generic peptide, custom peptide synthesis, custom antibody.  We offered peptide related products and services towards Pharmaceutical, Biotechnology and Life Sciences companies, and R&D institutes too. Our products are now well known in more than 30 countries. We have offices in major cities around the globe。With nearly 1,000 highly-trained staff and total 35,000 sqm. lab and production space , GL Biochem is now the largest manufacturer of research-grade peptides and peptide reagents globally.We applies the latest technology in our state-of-the-art production facilities to provide one-stop services for your needs and specifications.

Novasep and GTP Technology entered on March 21st 2016 in a partnership that combines their expertise in monoclonal antibody (mAb) production. The partners aim to facilitate the development of therapeutic and diagnostic candidates for European biopharmaceutical clients. This partnership offers biotech firms full CDMO services at all development stages from gene to end product.

GTP offers know-how in producing mAbs at the proof-of-concept /discovery and early clinical stages while Novasep provides expertise and plant facilities for preclinical and clinical stage production. The mid-size capacity and full range of services the partners offer fit closely with customer demand regarding expertise and fast-track process development. The partnership particularly targets mAb production for orphan drugs, ADCs and diagnostics.

MAbs are known to be complex to produce. As both upstream and downstream production steps have improved over the last decade, progress towards high-titer cultivation broth and high efficiency in purification suites has changed the processing technologies. The state-of-the-art DSP platform, based on the BioSC® continuous chromatography system that Novasep has designed, specifically addresses these new production challenges. This technical offering complements the CMO services Novasep provides for mAb production.

Novasep is a global provider of cost-effective and sustainable manufacturing solutions for life sciences molecules and fine chemicals. Novasep's unique offering includes process development services, purification equipment and turnkey processes, contract manufacturing services and complex active molecules to serve pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients as well as fermentation and chemical commodities industries.

GTP Technology is a contract research and development organization providing custom recombinant protein and process development services to support biopharmaceutical companies. Offering a unique mix of protein research and process cultures, GTP is able to handle projects from early discovery up to transfer to cGMP production for clinical studies.

Gyros Protein Technologies, enables peptide synthesis and bioanalytical solutions that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications.  Our low to mid-scale peptide synthesizer platforms are the Tribute®, Prelude® X, Symphony® X, and Sonata®. These solutions and our chemistries deliver uncompromising purity, flexibility, and quality for discovery and pre-clinical studies of simple to complex multifunctional peptides. Proprietary high performance nanoliter-scale immunoassay platforms, Gyrolab™xP workstation and GyrolabxPlore™, are used by scientists in leading pharmaceutical, biotech, CRO, and CMO companies for bioanalytical applications such as  pharmacokinetics/pharmacodynamics, immunogenicity, and quantitating bioprocess-related impurities. Our peptide synthesis and bioanalytical solutions accelerate your discovery, development, and manufacturing of safer biotherapeutics.

IBIS Technologies is a privately owned company developing, producing and distributing the IBIS MX96 for label-free profiling of 96 biomolecular interactions simultaneously using Surface Plasmon Resonance (SPR) imaging technology. The label-free and real time detection of (bio-) molecular interactions allows the instrument to be used for e.g. affinity measurements, immunoassays, binning of competing antibodies, epitope mapping of antigens and other high content diagnostics. The technology has been adopted by pharmaceutical multinationals, biotech companies and research institutes, where it has found its role in various research and screening applications.

IntelliCyt enables rapid, high content phenotypic and functional profiling of physiologically-relevant suspension cells, and multiplexed secreted protein assessment using bead-based assays. The iQue Screener family delivers more insight from less sample, in the least amount of time, providing a cost-effective means for making better decisions in personalized medicine and cell therapy applications.

Iris Biotech specializes in reagents for Drug Discovery, Drug Delivery, and Diagnostics. We have specific know-how and production capabilities to manufacture and supply products from the following areas:

1. Starting Materials for Peptide Synthesis, Peptidomimetics and Medicinal Chemistry
2. Technologies for Drug Delivery

Iris Biotech offers different linkers for the synthesis of Antibody-Drug-Conjugates (ADCs). Moreover, we provide the worldwide largest portfolio of PEGylating reagents, as well as a selection of certain poly(amino acids), which are biodegradable alternatives to PEG. Poly(glutamic acid) is a multivalent drug carrier system which is useful for diverse applications. Polysarcosine is a polypeptoid that shows excellent properties in terms of safety, synthetic control and versatility.

3. Reagents for Life Sciences and Diagnostics

This category includes enzyme substrates, inhibitors and inducers, metabolites, labeling reagents and cross-linkers, natural products with biological and pharmacological activity, carbohydrates, as well as dyes and fluorescent labels as tools for immunology, diagnostics, biochemistry and molecular biology.

4. Contract Manufacturing

We also provide Contract Manufacturing services in the above areas. Our strong points are, among other things, chiral small molecules (such as unnatural amino acids), complex heterocycles and monodisperse PEGs with various functional groups.

Our mission is to accompany our customers throughout their projects as a highly qualified supplier, all the way from R&D to production.

For more than 30 years, Lonza has been helping emerging and large biotech and pharmaceutical companies improve and advance their products. Whether for clinical or commercial supply, Lonza’s full set of development services, industry-leading manufacturing processes, global footprint, and broad chemical and biotechnology platforms enable you to optimize your time and costs throughout the pharmaceutical development process.

Lonza has the know-how and experience to handle almost any pharmaceutical or biotechnology challenge.  The company has industry leading experts specializing in active pharmaceutical ingredients (APIs), highly potent APIs, advanced intermediates, fine chemicals, antibody drug conjugates, peptides, vaccines, plasmid DNA, recombinant novel proteins, monoclonal antibodies, antibody fragments, cell-based therapeutics and viral-based therapeutics.

MaxCyte's flow electroporation is driving the next generation of cell-based medicines. Used in the discover, development, and manufacture of cell-based therapeutics, the MaxCyte GT® Flow Transfection System, MaxCyte STX® Scalable Transfection System, and MaxCyte VLX® Large Scale Transfection System enable the development of transfected cells for a range of applications.

From automated selection of high-expressing recombinant cell lines, to functional characterization of selected clones and quantitation of target proteins, our complete solutions for protein & antibody discovery/development and biotherapeutic production can help accelerate your time to discovery.

Cell line development for recombinant protein & antibody production

Develop stable cell lines with our solutions for:

• High-throughput screening and selection of mammalian cell lines or microbial colonies
• Selection of cells with optimal expression levels
• Simultaneous detection of colonies and quantification of fluorescent markers in a pre-screening step before picking
• Accurate selection and picking of colonies
• Objective and quantitative assessment of cell growth
• Verification of monoclonality

Products: ClonePix 2 System, CloneSelect Imager, QPix 400 Series Microbial Colony Pickers

Protein detection and quantification

Our instruments and reagents enable applications including:

• Bradford, BCA, Lowry, Protein (A₂₈₀), Nano Orange, and CBQCA assays
• Quantification of micro-volume amounts of protein
• Immunoassays,
• BRET and FRET assays
• Detection of enzyme activity
• Measurement of fluorescent protein expression
• Perform Western blot detection assays in your microplate reader with our ScanLater System

Products: Single and Multi-Mode Microplate Readers, SpectraMax QuickDrop Micro-Volume Spectrophotometer, ScanLater Western Blot Cartridge

NanoTemper Technologies is a globally operating, high-tech company providing solutions for biomolecular analytics, from basic to preclinical research. Our company develops, produces, and markets innovative technologies and instrumentation used by scientists across the globe to determine the affinity, conformation, and stability of biomolecules.

With headquarters in Munich, Germany, and subsidiaries in the UK, Poland, US, Brazil and India, our company is rapidly expanding worldwide. Among others, NanoTemper has been awarded the German Innovation Award 2012, the Bavarian Export Prize 2013 and the German Founders' Prize 2014. NanoTemper’s high-quality instruments are based on proprietary and innovative technologies.

NanoTemper’s MicroScale Thermophoresis (MST) technology is a unique method to study biomolecular binding affinities in an easy, fast, and precise way.

The Surface Acoustic Wave (SAW) technology quantifies binding-induced conformational changes, as well as measure binding kinetics.

The nanoDSF, Prometheus instruments, offers a method for measuring ultra-high-resolution protein stability and aggregation by using intrinsic tryptophan and tyrosine fluorescence.

Novasep and GTP Technology entered on March 21st 2016 in a partnership that combines their expertise in monoclonal antibody (mAb) production. The partners aim to facilitate the development of therapeutic and diagnostic candidates for European biopharmaceutical clients. This partnership offers biotech firms full CDMO services at all development stages from gene to end product.

GTP offers know-how in producing mAbs at the proof-of-concept /discovery and early clinical stages while Novasep provides expertise and plant facilities for preclinical and clinical stage production. The mid-size capacity and full range of services the partners offer fit closely with customer demand regarding expertise and fast-track process development. The partnership particularly targets mAb production for orphan drugs, ADCs and diagnostics.

MAbs are known to be complex to produce. As both upstream and downstream production steps have improved over the last decade, progress towards high-titer cultivation broth and high efficiency in purification suites has changed the processing technologies. The state-of-the-art DSP platform, based on the BioSC® continuous chromatography system that Novasep has designed, specifically addresses these new production challenges. This technical offering complements the CMO services Novasep provides for mAb production.

Novasep is a global provider of cost-effective and sustainable manufacturing solutions for life sciences molecules and fine chemicals. Novasep's unique offering includes process development services, purification equipment and turnkey processes, contract manufacturing services and complex active molecules to serve pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients as well as fermentation and chemical commodities industries.

GTP Technology is a contract research and development organization providing custom recombinant protein and process development services to support biopharmaceutical companies. Offering a unique mix of protein research and process cultures, GTP is able to handle projects from early discovery up to transfer to cGMP production for clinical studies.

Pepscan is an ISO 9001:2008 certified provider of peptide-based products & services, including custom peptide synthesis, epitope mapping and peptide arrays. With its comprehensive range of specialty peptide services Pepscan serves a global clientele, from university research groups to biotech and large pharma companies. In addition Pepscan applies its profound know-how of peptides for the discovery and optimization of new peptide drugs in collaborative R&D project. Pepscan specializes in constrained peptides and the inventor of the CLIPS constraining technology. Its bicyclic ‘2-CLIPS’ peptides represent a new generation of biotherapeutics, offering antibody-like affinity and selectivity in a small (<2kD), fully synthetic molecule.

With over 25 years of expetise in peptide synthesis, Pepscan is a premier supplier of high quality peptides. With highly skilled and committed scientists, we are full capable of meeting the gorwing needs for peptides in life science research.

Pepscan is based in Lelystad, the Netherlands, and can be reached via [email protected] or www.pepscan.com .

POLYPURE, the PEG designer

Polypure AS is producing high quality single-length or uniform polyethylene glycol (PEG) and PEG derivatives for advanced applications.

Monodisperse PEG linkers are used to improve solubility and pharmacokinetic properties of peptides, proteins, biopharmaceuticals and organic drug molecules.

Our PEGs are thoroughly fractionated by proprietary chromatography from polydisperse PEG to individual components. These ultrapure PEGs are no longer polymer mixtures. Our products contain less than 2% n-1 (polydispersity <1.0002).

The perfect monodispersity of our PEG reagents ensures consistent quality, product characterization and reproducibility of the results.

A broad selection of heterofunctional derivatives of PEG from MW400 range up to 5KDa can be supplied in several configurations to satisfy your needs for precision tool chemicals.

Polypure catalogue contains protected amines and amino PEG acids (Fmoc, Boc-protected), maleimido PEG and PEG thiol derivatives as well as a range of conjugation reagents from gram to multi-kilograms quantities.

Polypure AS – Oslo Research Park - Gaustadalleen 21 -  NO-0349 OSLO - Norway

www.polypure.com

Tel: +47 21 08 07 40    Email: [email protected]

Our new corporate name is Provepharm Solutions and we are composed of 2 services entities. Our small molecules business unit, formerly Provence Technologies, is a CRO specializing in small molecule chemical synthesis and process development (up to 1500Da). Our peptide business unit, formerly Provepep, is a CDMO specializing in peptide and protein solid phase chemistry (20 to 250mer), with a GMP certified production unit. We have developed several peptide-based products (polyepitopic peptides, peptide mixture, lipopeptides, cell penetrating peptides, immunoconjugates, peptide ligands,…)  from sequence and chemical design up to API commercial needs.

Provepharm Solutions is part of Provepharm Group.

Quinta-Analytica – Quality in Time

Quinta-Analytica is a a contract research organization whose primary task is to supply pharmaceutical companies with analytical service. Quinta-Analytica’s activity is mainly focused in studies and analyses required by regulatory authorities before a pharmaceutical company can introduce its new products to market.

Our company covers analytical service from research and development of methods to their application in both bioanalyses (bioequivalence, pharmacokinetics/toxicokinetics, clinical study monitoring) and pharmaceutical analyses (method validation, release testing, stability studies). This analytical service includes testing of large molecules of biopharmaceuticals.

Biopharmaceuticals represent a significant part of the pharmaceutical market. Quinta-Analytica offer comprehesive analytical testing of high-molecular weight pharmaceuticals, such as proteins and peptides, including analyses in GMP/GLP/GCP environment. We also test samples and evaluate  preclinical and/or clinical trials on biosimilars/biopharmaceuticals.

Unique specialties are testing of dry powder inhalation products, impurity structure elucidations combined with custom synthesis, reverse engineering, solutions for complaint batches and in-vitro clinical studies.

Quinta-Analytica has substantially enlarged its activities in clinical trials. It offers various clinical trials like bioavailability/bioequivalence and biodrug/biosimilars testing, safety and tolerability, PK/PD studies, dose-ranging and linearity. Quinta-Analytica has a team of experts with long-term experience in pharmacokinetic/bioequivalence studies of different design carried out for EU and USA.

Main advantage of Quinta-Analytica is the concentration of the analytical services at one place. Clinical unit with 60 beds, most-modern bioanalytical laboratory, laboratory for biopharmaceuticals, quality control lab, ICH stability chambers, analytical method development department and headquarters are located on one address. It enables to provide complete service (“turnkey contract”) or customized services in accordance to the sponsor’s requirements.

During the years from its foundation in 1997, it became the largest CRO in the Central and Eastern Europe. Focused, experienced and well-organized company, operating on the world market from the very beginning offers analytical expertise needed for your pharmaceutical projects. Its location in the middle of Europe (Prague, Czech Republic) gives a decisive advantage for pharmaceutical company logistics.

Quinta-Analytica is regularly inspected by national as well as international regulatory authorities. To date, Quinta-Analytica passed 10 GXP audits by U.S. Food and Drug Administration (FDA).

Schrödinger makes significant investments in R&D, which has led to major advances in the field of computational chemistry. Working closely with its scientific advisory board – a distinguished group of leading academic and industrial scientists who collectively have thousands of publications, many of which represent groundbreaking advances – Schrödinger has achieved breakthroughs in quantum chemistry, molecular modeling, force fields, molecular dynamics, protein structure determination, scoring, and virtual screening. Schrödinger's methods development and applications papers have thousands of citations and are often among the most-cited scientific publications. Schrödinger's science is continually validated internally and by its users worldwide.

The company's full product offerings range from general molecular modeling programs to a comprehensive suite of drug design software, as well as a state-of-the-art suite for materials research. Schrödinger is developing enterprise level software that can be deployed throughout an entire research organization, and the company is committed to providing integrated software solutions and services that truly meet its customers’ needs. Schrödinger wants to empower researchers around the world to achieve their goals of improving human health and quality of life through advanced computational techniques that transform the way chemists design compounds and materials. By building and deploying breakthrough scientific software solutions and forming collaborations and partnerships, Schrödinger helps scientists accelerate their research and development activities, reduce costs, and make novel discoveries that might otherwise not be possible.

Founded in 1990, Schrödinger has operations in several locations within the United States as well as in Europe, India, and Japan.

Incorporated in 1993 as a subsidiary of Biocon Limited, Syngene is a leading custom research and manufacturing organization, which supports R&D programs from lead generation to clinical supplies. Our multi-disciplinary skills in integrated drug discovery and development include capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation, analytical development, bioinformatics along with clinical development services.

Our highly experienced scientific and project management teams ensure:

• Timely execution of projects
• Cost effectiveness and quality of the projects
• Confidentiality and protection of intellectual property

Syngene has state-of-the-art research facilities certified with ISO 9001:2008, ISO 14001:2004, and OHSAS 18001:2007. Our animal facilities are GLP certified by the Indian authorities and AAALAC accredited. Over the last 20 years, we have successfully offered these services to more than 250 clients including start-up companies, large pharma/ biotech, agrochemical, chemical, nutrition and animal health companies in the USA, Europe and Asia Pacific including Japan.

Syngene has a strong corporate governance framework with a focus on client satisfaction, quality, safety, ethics and integrity. Our ability to deliver significant value to our customers by leveraging our scientific skills, global mind set and India’s cost competitiveness differentiates us as one of the most preferred partners.

TTP Labtech designs and manufactures robust and easy-to-use solutions for cell or bead based immunodetection, sample management & liquid handling. We enable life scientists through collaboration, deep application knowledge and leading engineering to accelerate research and make a difference together. We will be showcasing the mirrorball fluorescence cytometer, which removes productivity barriers within antibody discovery. Efficient no-wash multiplexed protocols make light work of hit screening and characterisation using sol-R™ coded beads, or cell-based immunoassays. mirrorball’s no-fluidics design offers screening reliability and economical cost of ownership. Rapidly progress lead candidates on-time and within budget using mirrorball.